CTI appoints medical director
This article was originally published in Scrip
Executive Summary
Clinical trial and consulting service provider CTI has named Dr Ralph Campaneria medical director. Prior to joining Cincinnati, Ohio-based CTI, Dr Campaneria was medical director at biopharmaceutical firm Inhibitex. His therapeutic background includes industry and clinical experience in hematology, dermatology, immunology, infectious disease, and psychiatry.